Live Quote · NASDAQXTLBHealthcare· Biotechnology

XTL Biopharmaceuticals Ltd.

$1.37▼ 7.43%($-0.11)
MKT CAP $1.30MLAST EARNINGS Apr 29, 2026
50%
Bullish
TickerSpark Score
32/100
▌ Poor
60
Valuation
20
Profitability
10
Growth
40
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XTLB research report →

Analyst RatingBuy
2 Buy0 Hold0 Sell

Price Chart

-57.85% · this period
$4.28$2.83$1.37Nov 20May 26Nov 20
52-Week Range0% of range
Low
$1.37
Current
$1.37
High
$5.64